Effects of Fenofibrate on Gene Expression in Healthy Volunteers
- First Posted Date
- 2010-04-23
- Last Posted Date
- 2010-04-23
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 26
- Registration Number
- NCT01109758
- Locations
- π¬π§
Site 1, London, United Kingdom
A Methodological Study To Evaluate The Effects of Single Oral Doses Of Pioglitazone 45 mg And Rosiglitazone 8 mg On Sodium Balance In Healthy Male Volunteers
Phase 1
Completed
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- Drug: pioglitazone/rosiglitazone/placeboDrug: rosiglitazone/pioglitazone/placeboDrug: placebo/pioglitazone/rosiglitazoneDrug: pioglitazone/placebo/rosiglitazoneDrug: rosiglitazone/placebo/pioglitazoneDrug: placebo/rosiglitazone/pioglitazone
- First Posted Date
- 2010-03-17
- Last Posted Date
- 2010-03-17
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 12
- Registration Number
- NCT01088594
- Locations
- π¬π§
S337.1.004 Site #, London, United Kingdom
Study to Investigate ADME of 14C Labeled SLV334 After an i.v. Infusion
Phase 1
Completed
- Conditions
- Pharmacology, Clinical
- Interventions
- Radiation: SLV 334
- First Posted Date
- 2010-01-08
- Last Posted Date
- 2010-09-17
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 6
- Registration Number
- NCT01044524
- Locations
- π³π±
S334.1.004 - Site 1, Zuid-Laren, Netherlands
Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure
- First Posted Date
- 2009-10-21
- Last Posted Date
- 2009-11-25
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 24
- Registration Number
- NCT00998933
- Locations
- πΊπΈ
Site 1, Miami Gardens, Florida, United States
Interaction Study SLV337/Simvastatin
Phase 1
Completed
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- Drug: Simvastatin- SLV337 SD beta- SLV337 SD alpha - SLV337 MD beta- SLV337 SD beta+ Simvastatin
- First Posted Date
- 2009-06-19
- Last Posted Date
- 2009-09-09
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 16
- Registration Number
- NCT00924430
- Locations
- π¬π§
Site 1, London, United Kingdom
First in Man Study With SLV341
- First Posted Date
- 2009-04-24
- Last Posted Date
- 2010-04-28
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 87
- Registration Number
- NCT00887445
- Locations
- π¬π§
S341.1.001 Site #, London, United Kingdom
Safety and Tolerability of the First IV Dosing of SLV338 in Healthy Volunteers
- First Posted Date
- 2009-04-22
- Last Posted Date
- 2010-01-29
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 42
- Registration Number
- NCT00885989
- Locations
- π¬π§
Site 1, London, United Kingdom
Effect of Fenofibrate on Sleep Apnea Syndrome
Phase 2
Terminated
- Conditions
- DyslipidemiaSleep Apnea SyndromeOverweightObesity
- Interventions
- Drug: Placebo
- First Posted Date
- 2009-01-05
- Last Posted Date
- 2009-07-22
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 34
- Registration Number
- NCT00816829
- Locations
- π«π·
Site 1, Paris, France
Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis
Phase 3
Completed
- Conditions
- Cystic FibrosisPancreatic Exocrine Insufficiency
- Interventions
- First Posted Date
- 2008-10-20
- Last Posted Date
- 2010-11-07
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 19
- Registration Number
- NCT00775528
- Locations
- πΊπΈ
Site 9, Boston, Massachusetts, United States
πΊπΈSite 5, Louisville, Kentucky, United States
πΊπΈSite 12, Detroit, Michigan, United States
Safety and Efficacy Study to Evaluate the Effect of SLV320 on Renal Function in Patients With Worsening Heart Failure
Phase 2
Terminated
- Conditions
- Acute Decompensated Heart Failure; Renal Dysfunction
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-08-29
- Last Posted Date
- 2010-09-17
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 46
- Registration Number
- NCT00744341
- Locations
- πΊπΈ
S320.2.011 Site # 526, Owensboro, Kentucky, United States
πΊπΈS320.2.011 Site # 511, Houston, Texas, United States
πΊπΈS320.2.011 Site # 518, San Antonio, Texas, United States
Β© Copyright 2025. All Rights Reserved by MedPath